<DOC>
	<DOCNO>NCT01466374</DOCNO>
	<brief_summary>The purpose study determine whether BMS-936557 effective treatment moderate severely active Crohn 's Disease patient insufficient response and/or intolerance conventional therapy Crohn 's Disease .</brief_summary>
	<brief_title>Induction Maintenance Study BMS-936557 Patients With Moderate Severely Active Crohn 's Disease</brief_title>
	<detailed_description>Anti-IP10 : Anti Interferon-inducible ligand 10</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Adults subject confirm Crohn 's Disease ( CD ) least 3 month Moderate severely active CD define Crohn 's Disease Activity Index ( CDAI ) 220 450 In past insufficient response intolerance â‰¥ 1 conventional therapy ( immunosuppressant , corticosteroid and/or approve biologic therapy ) Ulcerative colitis ( UC ) indeterminate colitis Short bowel syndrome Known stricture noninflammatory stenosis lead symptom obstruction Current stoma current need colostomy ileostomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>